rs7910428

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1

The NM_006258.4(PRKG1):​c.1001+10501G>A variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.235 in 152,120 control chromosomes in the GnomAD database, including 4,473 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.24 ( 4473 hom., cov: 33)

Consequence

PRKG1
NM_006258.4 intron

Scores

2

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: -0.758

Publications

4 publications found
Variant links:
Genes affected
PRKG1 (HGNC:9414): (protein kinase cGMP-dependent 1) Mammals have three different isoforms of cyclic GMP-dependent protein kinase (Ialpha, Ibeta, and II). These PRKG isoforms act as key mediators of the nitric oxide/cGMP signaling pathway and are important components of many signal transduction processes in diverse cell types. This PRKG1 gene on human chromosome 10 encodes the soluble Ialpha and Ibeta isoforms of PRKG by alternative transcript splicing. A separate gene on human chromosome 4, PRKG2, encodes the membrane-bound PRKG isoform II. The PRKG1 proteins play a central role in regulating cardiovascular and neuronal functions in addition to relaxing smooth muscle tone, preventing platelet aggregation, and modulating cell growth. This gene is most strongly expressed in all types of smooth muscle, platelets, cerebellar Purkinje cells, hippocampal neurons, and the lateral amygdala. Isoforms Ialpha and Ibeta have identical cGMP-binding and catalytic domains but differ in their leucine/isoleucine zipper and autoinhibitory sequences and therefore differ in their dimerization substrates and kinase enzyme activity. [provided by RefSeq, Sep 2011]
PRKG1 Gene-Disease associations (from GenCC):
  • aortic aneurysm, familial thoracic 8
    Inheritance: AD Classification: STRONG, MODERATE Submitted by: Labcorp Genetics (formerly Invitae), Ambry Genetics
  • familial thoracic aortic aneurysm and aortic dissection
    Inheritance: AD Classification: STRONG, SUPPORTIVE Submitted by: ClinGen, Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.92).
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.314 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_006258.4. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
PRKG1
NM_006258.4
MANE Select
c.1001+10501G>A
intron
N/ANP_006249.1
PRKG1
NM_001098512.3
c.956+10501G>A
intron
N/ANP_001091982.1
PRKG1
NM_001374781.1
c.-209+10501G>A
intron
N/ANP_001361710.1

Ensembl Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
PRKG1
ENST00000373980.11
TSL:1 MANE Select
c.1001+10501G>A
intron
N/AENSP00000363092.5
PRKG1
ENST00000401604.8
TSL:5
c.956+10501G>A
intron
N/AENSP00000384200.4
PRKG1
ENST00000672084.1
c.152+10501G>A
intron
N/AENSP00000499822.1

Frequencies

GnomAD3 genomes
AF:
0.236
AC:
35809
AN:
152002
Hom.:
4474
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.319
Gnomad AMI
AF:
0.123
Gnomad AMR
AF:
0.234
Gnomad ASJ
AF:
0.273
Gnomad EAS
AF:
0.228
Gnomad SAS
AF:
0.143
Gnomad FIN
AF:
0.168
Gnomad MID
AF:
0.313
Gnomad NFE
AF:
0.201
Gnomad OTH
AF:
0.256
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome
AF:
0.235
AC:
35817
AN:
152120
Hom.:
4473
Cov.:
33
AF XY:
0.232
AC XY:
17272
AN XY:
74366
show subpopulations
African (AFR)
AF:
0.318
AC:
13204
AN:
41458
American (AMR)
AF:
0.234
AC:
3578
AN:
15282
Ashkenazi Jewish (ASJ)
AF:
0.273
AC:
946
AN:
3470
East Asian (EAS)
AF:
0.228
AC:
1181
AN:
5178
South Asian (SAS)
AF:
0.143
AC:
690
AN:
4824
European-Finnish (FIN)
AF:
0.168
AC:
1781
AN:
10590
Middle Eastern (MID)
AF:
0.303
AC:
89
AN:
294
European-Non Finnish (NFE)
AF:
0.201
AC:
13695
AN:
67998
Other (OTH)
AF:
0.256
AC:
541
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.504
Heterozygous variant carriers
0
1386
2772
4157
5543
6929
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
364
728
1092
1456
1820
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.219
Hom.:
10662
Bravo
AF:
0.247
Asia WGS
AF:
0.179
AC:
620
AN:
3478

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.92
CADD
Benign
1.5
DANN
Benign
0.46
PhyloP100
-0.76
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs7910428; hg19: chr10-53904166; API